[3] [6] While mild reflux symptoms may be manageable with conservative measures, certain warning signs warrant prompt medical evaluation
Impact on Blood Sugar Medications: For people with diabetes, any delay in medication absorption might influence blood sugar control
The global GLP-1 Weight Loss Drug Market encompasses glucagon-like peptide-1 receptor agonists, dual GIP/GLP-1 agonists, and emerging triple-receptor agonists approved or in development for chronic weight management, type 2 diabetes remission, and metabolic disease intervention
Use in Special Populations Pediatric population: The safety and efficacy of Semaglo in children and adolescents below 18 years have not yet been established
Wegovy works by: Slowing gastric emptying , which helps you feel fuller for longer after meals Acting on appetite centres in the brain to reduce hunger and food cravings Improving glycaemic control through enhanced insulin secretion when blood glucose is elevated Administered as a once-weekly subcutaneous injection, Wegovy is started at a low dose (0.25 mg) and gradually increased over 16 weeks to the maintenance dose of 2.4 mg to improve tolerability
